National Health (Weighted average disclosed price – first transitional disclosure cycle) Determination 2011 (No. PB 81 of 2011) (Cth)

Case

National Health (Weighted average disclosed price – first transitional disclosure cycle) Determination 2011

Instrument number PB 81 of 2011

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the National Health Act 1953.

Dated 13 December 2011

FELICITY McNEILL

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health and Ageing

Part 1         Preliminary

  1. Name of Determination

(1)     This Determination is the National Health (Weighted average disclosed price – first transitional disclosure cycle) Determination 2011.

(2)     This Determination may also be cited as PB 81 of 2011.

  1. Commencement

This Determination commences on the day after it is registered.

  1. Revocation

The Determination titled ‘Determination made pursuant to subsections 99ADB(4) and 99ADB(5) of the National Health Act 1953’ made on 22 September 2010 and also cited as PB 43 of 2010 is revoked.

  1. Definitions

In this Determination:

Act means the National Health Act 1953.

adjusted approved ex-manufacturer price has the same meaning as in subsection 99ADB(1) of the Act.

adjusted approved price to pharmacists has the same meaning as in subsection 99ADB(1) of the Act.

first transitional disclosure cycle has the same meaning as in Part 2 Transitional, regulation 4, of the National Health (Pharmaceutical Benefits) Amendment Regulations 2010 (No.5) (296/2010).

unadjusted price reduction has the same meaning as in subsection 99ADB(1) of the Act.

weighted average disclosed price has the same meaning as in subsection 99ADB(1) of the Act.

  1. Weighted average disclosed price for brands of pharmaceutical items – unadjusted price reduction is at least 10%

For subsection 99ADB(4) of the Act, the weighted average disclosed price specified in column 3 of an item in Schedule 1 is the weighted average disclosed price for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 1.

  1. Weighted average disclosed price for brands of pharmaceutical items – unadjusted price reduction is less than 10%

For subsection 99ADB(4) of the Act, the weighted average disclosed price specified in column 3 of an item in Schedule 2 is the weighted average disclosed price for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 2.

  1. Adjusted approved ex-manufacturer price for brands of pharmaceutical items – unadjusted price reduction is at least 10%

For paragraph 99ADB(4) of the Act, the adjusted approved ex-manufacturer price for a brand of pharmaceutical item specified in column 2 of Schedule 1 is an amount equal to the amount of the weighted average disclosed price of that brand of pharmaceutical item determined under section 5 of this instrument.

  1. Adjusted approved price to pharmacists for brands of pharmaceutical items – unadjusted price reduction is at least 10%

For paragraph 99ADB(4) of the Act, the adjusted approved price to pharmacists specified in column 4 of an item in Schedule 1 is the adjusted approved price to pharmacists for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 1.

  1. Reduction Day

For paragraph 99ADH(1)(aa) of the Act, a brand of pharmaceutical item in the first transitional disclosure cycle with a data collection period ending at the end of
30 September 2011 has a reduction day of 1 April 2012.


Schedule 1            

Brands of pharmaceutical items – unadjusted price reduction is at least 10%

Column 1 Column 2 Column 3 Column 4
Item Brand of Pharmaceutical Item Weighted average disclosed price Adjusted approved price to pharmacists
Listed Drug Form Manner of administration Brand
1 Alendronic Acid Tablet 40 mg (as alendronate sodium) Oral Fosamax 40 mg 56.35 60.59
2 Alendronic Acid Tablet 70 mg (as alendronate sodium) Oral Adronat 17.07 18.35
3 Alendronic Acid Tablet 70 mg (as alendronate sodium) Oral Alendro Once Weekly 17.07 18.35
4 Alendronic Acid Tablet 70 mg (as alendronate sodium) Oral Alendrobell 70mg 17.07 18.35
5 Alendronic Acid Tablet 70 mg (as alendronate sodium) Oral Alendronate Sandoz 17.07 18.35
6 Alendronic Acid Tablet 70 mg (as alendronate sodium) Oral Alendronate-GA 17.07 18.35
7 Alendronic Acid Tablet 70 mg (as alendronate sodium) Oral APO-Alendronate 17.07 18.35
8 Alendronic Acid Tablet 70 mg (as alendronate sodium) Oral Chem mart Alendronate 70mg 17.07 18.35
9 Alendronic Acid Tablet 70 mg (as alendronate sodium) Oral Fosamax Once Weekly 17.07 18.35
10 Alendronic Acid Tablet 70 mg (as alendronate sodium) Oral Ossmax 70mg 17.07 18.35
11 Alendronic Acid Tablet 70 mg (as alendronate sodium) Oral Terry White Chemists Alendronate 70mg 17.07 18.35
12 Cisplatin I.V. injection 10 mg in 10 mL Injection Pfizer Australia Pty Ltd 2.78 2.99
13 Cisplatin I.V. injection 100 mg in 100 mL Injection Cisplatin Ebewe 18.79 20.20
14 Cisplatin I.V. injection 100 mg in 100 mL Injection Hospira Pty Limited 18.79 20.20
15 Cisplatin I.V. injection 100 mg in 100 mL Injection Pfizer Australia Pty Ltd 18.79 20.20
16 Cisplatin I.V. injection 50 mg in 50 mL Injection Hospira Pty Limited 7.46 8.02
17 Cisplatin I.V. injection 50 mg in 50 mL Injection Pfizer Australia Pty Ltd 7.46 8.02
18 Fluconazole Capsule 100 mg Oral DBL Fluconazole 55.24 59.39
19 Fluconazole Capsule 100 mg Oral Diflucan 55.24 59.39
20 Fluconazole Capsule 100 mg Oral Dizole 100 55.24 59.39
21 Fluconazole Capsule 100 mg Oral Fluconazole Sandoz 55.24 59.39
22 Fluconazole Capsule 100 mg Oral Ozole 55.24 59.39
23 Fluconazole Capsule 200 mg Oral APO-Fluconazole 107.61 115.70
24 Fluconazole Capsule 200 mg Oral DBL Fluconazole 107.61 115.70
25 Fluconazole Capsule 200 mg Oral Diflucan 107.61 115.70
26 Fluconazole Capsule 200 mg Oral Dizole 200 107.61 115.70
27 Fluconazole Capsule 200 mg Oral Fluconazole Sandoz 107.61 115.70
28 Fluconazole Capsule 200 mg Oral Fluzole 200 107.61 115.70
29 Fluconazole Capsule 200 mg Oral Ozole 107.61 115.70
30 Fluconazole Capsule 50 mg Oral DBL Fluconazole 28.36 30.49
31 Fluconazole Capsule 50 mg Oral Diflucan 28.36 30.49
32 Fluconazole Capsule 50 mg Oral Dizole 50 28.36 30.49
33 Fluconazole Capsule 50 mg Oral Fluconazole Sandoz 28.36 30.49
34 Fluconazole Capsule 50 mg Oral Fluzole 50 28.36 30.49
35 Fluconazole Capsule 50 mg Oral Ozole 28.36 30.49
36 Topiramate Capsule 15 mg Oral Topamax Sprinkle 17.68 19.01
37 Topiramate Capsule 25 mg Oral Topamax Sprinkle 23.90 25.70
38 Topiramate Capsule 50 mg Oral Topamax Sprinkle 39.84 42.84
39 Topiramate Tablet 100 mg Oral APO-Topiramate 62.75 67.47
40 Topiramate Tablet 100 mg Oral Epiramax 100 62.75 67.47
41 Topiramate Tablet 100 mg Oral RBX Topiramate 62.75 67.47
42 Topiramate Tablet 100 mg Oral Tamate 62.75 67.47
43 Topiramate Tablet 100 mg Oral Topamax 62.75 67.47
44 Topiramate Tablet 100 mg Oral Topiramate generichealth 62.75 67.47
45 Topiramate Tablet 100 mg Oral Topiramate Sandoz 62.75 67.47
46 Topiramate Tablet 100 mg Oral Topiramate-GA 62.75 67.47
47 Topiramate Tablet 200 mg Oral APO-Topiramate 105.41 113.34
48 Topiramate Tablet 200 mg Oral Epiramax 200 105.41 113.34
49 Topiramate Tablet 200 mg Oral RBX Topiramate 105.41 113.34
50 Topiramate Tablet 200 mg Oral Tamate 105.41 113.34
51 Topiramate Tablet 200 mg Oral Topamax 105.41 113.34
52 Topiramate Tablet 200 mg Oral Topiramate generichealth 105.41 113.34
53 Topiramate Tablet 200 mg Oral Topiramate Sandoz 105.41 113.34
54 Topiramate Tablet 200 mg Oral Topiramate-GA 105.41 113.34
55 Topiramate Tablet 25 mg Oral APO-Topiramate 24.30 26.13
56 Topiramate Tablet 25 mg Oral Epiramax 25 24.30 26.13
57 Topiramate Tablet 25 mg Oral RBX Topiramate 24.30 26.13
58 Topiramate Tablet 25 mg Oral Tamate 24.30 26.13
59 Topiramate Tablet 25 mg Oral Topamax 24.30 26.13
60 Topiramate Tablet 25 mg Oral Topiramate generichealth 24.30 26.13
61 Topiramate Tablet 25 mg Oral Topiramate Sandoz 24.30 26.13
62 Topiramate Tablet 25 mg Oral Topiramate-GA 24.30 26.13
63 Topiramate Tablet 50 mg Oral APO-Topiramate 39.89 42.89
64 Topiramate Tablet 50 mg Oral Epiramax 50 39.89 42.89
65 Topiramate Tablet 50 mg Oral RBX Topiramate 39.89 42.89
66 Topiramate Tablet 50 mg Oral Tamate 39.89 42.89
67 Topiramate Tablet 50 mg Oral Topamax 39.89 42.89
68 Topiramate Tablet 50 mg Oral Topiramate generichealth 39.89 42.89
69 Topiramate Tablet 50 mg Oral Topiramate Sandoz 39.89 42.89
70 Topiramate Tablet 50 mg Oral Topiramate-GA 39.89 42.89

Schedule 2            

Brands of pharmaceutical items – unadjusted price reduction is less than 10%

Column 1 Column 2 Column 3
Item Brand of Pharmaceutical Item Weighted average disclosed price
Listed Drug Form Manner of administration Brand
1 Levodopa with Carbidopa Tablet 100 mg-25 mg (anhydrous) Oral Kinson 25.47
2 Levodopa with Carbidopa Tablet 100 mg-25 mg (anhydrous) Oral Sinemet 100/25 25.47
3 Levodopa with Carbidopa Tablet 250 mg-25 mg (anhydrous) Oral Levo/Carbidopa Sandoz 31.41
4 Levodopa with Carbidopa Tablet 250 mg-25 mg (anhydrous) Oral Sinemet 31.41
5 Naltrexone Tablet containing naltrexone hydrochloride 50 mg Oral Naltrexone generichealth 108.89
6 Naltrexone Tablet containing naltrexone hydrochloride 50 mg Oral ReVia 108.89

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0